« FDA Approves Teva's Generic Lexapro | Main | Novartis AG Will Launch Anti-Malaria Project »

May26
NRP104 Passed Phase III Clinical Trial for Treatment of ADHD

Treatment with the investigational drug lisdexamfetamine dimesylate (NRP104) showed a statistically significant reduction in the symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged 6 to 12 years as demonstrated by the results oaf a Phase III Clinical Trial recently presented at the annual meeting of the American Psychiatric Association (APA).

NRP104 has been developed by New River Pharmaceuticals Inc. but being co-developed and commercialized by Shire plc.

Also presented at APA is the Phase II trial of NRP104 that demonstrated a statistically significant reduction in ADHD symptoms comparable to mixed amphetamine salts extended-release (MAS XR).

Read more at Shire press release.

related entries


0 Comments/Trackbacks




submit a trackback

TrackBack URL for this entry:

post a comment

Name, Email Address, and URL are not required fields.





Comment Preview

« FDA Approves Teva's Generic Lexapro | Main | Novartis AG Will Launch Anti-Malaria Project »

Advertise

Watch the Digital Health Revolution


sponsored ads



subscribe


Prefer Email?
Subscribe below-

Enter your Email:


Powered by FeedBlitz What's this?

Current News

Support This Blog

top blogs

business social media

Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

BIZZlogos - Add your logo - free link to your site
BIZZphotos - Add photos of your products and people
BIZZprofiles - Submit your profile and build your online visibility
BIZZspotlight - Spotlight your business with free links
BIZZvideos - Videos about businesses, products and business people.
BIZZbites - "Digg" for Business - Submit your articles and posts

Know More Media - Health Care / Pharmaceutical / Fitness

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed


we support unitus

PRWeb

Influencer



PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

LandingTheDeal

CustomersAreAlways

HealthCareVox

BrainBasedBusiness

TheInsurancePolicy

MarketingBlurb